NRG1-ERBB signaling influences the risk for schizophrenia pathology. A recent study has reported that MAGI1, MAGI2, and protein tyrosine phosphatase, receptor-type, Z polypeptide 1 (PTPRZ1; located on 7q31.3) gene products regulate the NRG1-ERBB4 signaling pathway, and PTPRZ1 is associated with schizophrenia in a Caucasian population. By applying a gene-based association concept, we analyzed any association between PTPRZ1 tagging SNPs and schizophrenia in the Japanese population (576 schizophrenics and 768 controls). After linkage disequilibrium analysis, 29 single nucleotide polymorphisms (SNPs) were genotyped using a 50-exonuclease allelic discrimination assay. We found a significant associationof one tagging SNP in a genotype-wise analysis (P = 0.007); however, this might be resulted from type I error due to multiple testing (P = 0.17 after SNPSpD correction). No association was observed between schizophrenic patients and controls in either allelic, genotypic, or haplotypic analyses. Our results therefore suggest that PTPRZ1 is unlikely to be related to the development of schizophrenia in the Japanese population. © 2008 Wiley-Liss, Inc.
CITATION STYLE
Ito, Y., Yamada, S., Takahashi, N., Saito, S., Yoshimi, A., Inada, T., … Ozaki, N. (2008). No association between the protein tyrosine phosphatase, receptor-type, Z polypeptide 1 (PTPRZ1) gene and schizophrenia in the Japanese population. American Journal of Medical Genetics, Part B: Neuropsychiatric Genetics, 147(7), 1013–1018. https://doi.org/10.1002/ajmg.b.30692
Mendeley helps you to discover research relevant for your work.